CEL-G ®TTWELDER-6 Aseptic takeover machine is a method of connecting two pipelines by cutting and reconnecting a catheter at high temperature usin...
01 /
-
-
The CEL-G®Culture Ad600 series bioreactors are designed for high-volume adherent cell culture. The unique membrane structure provides a high-capac...
-
CEL-G® Culture Ad60 series fixed-bed bioreactors are suitable for large-scale cGMP-grade viral production. The unique technology provides a low-sh...
-
Tongteng Xinchuang's self-developed CEL-G®TFF Lab series exosome concentration system is an automated processing equipment based on the princ...
Tongteng Innovation （Suzhou）Co., Ltd. has invested 50 million yuan to establish a production factory in Taicang, Jiangsu. Currently, the CEL-G, which is independently developed and put into operation, has been launched for the market ® Culture Ad60 Series fixed bed bioreactors and CEL-G ® TFF lab Series exosome concentration system, CEL-G ® TTWELDER-6 Aseptic takeover machine, CEL-G ® Culture Ad600 The series of fixed bed bioreactors provide high-quality localized cell research and production solutions for cell and gene therapy, antibody and vaccine manufacturing enterprises.
-
The company passed the high-tech enterprise certification
-
Invention Patent
-
Software Copyright
-
Intellectual Property
- 021-50826962
- sales@ttbiotech.com
-
No. 90 Zhaoxi Road, Taicang City, Suzhou City, Jiangsu Province
Copyright © 2024 Tongteng Innovation （Suzhou）Co., Ltd. All Rights Reserved. 苏ICP备2024101917号